SCHEMBL14867973

SCHEMBL14867973

c1ccc2c(c1)c1ccccc1n2-c1ccc2sc3ccc(-n4c5ccc(-n6c7ccccc7c7ccccc76)cc5c5cc(-n6c7ccccc7c7ccccc76)ccc54)cc3c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
ATM Q13315 1/20 0.48
GPR3 P46089 2/20 0.40
MAPT P10636 4/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 3/20 0.34
MEN1 O00255 2/20 0.34
HTT P42858 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPK1 P28482 1/20 0.33
HBB P68871 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
RAC2 P15153 1/20 0.33
RAC3 P60763 1/20 0.33
CDC42 P60953 1/20 0.33
RAC1 P63000 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21671373 1.00 KDM4E (0.48) KDM4EL3MBTL1ATMGPR3MAPT
SCHEMBL26049262 1.00 KDM4E (0.48) KDM4EL3MBTL1ATMGPR3MAPT
SCHEMBL10029287 0.97 GPR3 (0.47) KDM4EL3MBTL1ATMGPR3MAPT
SCHEMBL10450024 0.97 GPR3 (0.47) KDM4EL3MBTL1ATMGPR3MAPT
SCHEMBL127309 0.97 GPR3 (0.47) KDM4EL3MBTL1ATMGPR3MAPT
SCHEMBL29397828 0.96 KDM4E (0.52) KDM4EL3MBTL1ATMGPR3MAPT
SCHEMBL126273 0.96 KDM4E (0.52) KDM4EL3MBTL1ATMGPR3MAPT
SCHEMBL29398379 0.96 KDM4E (0.52) KDM4EL3MBTL1ATMGPR3MAPT
SCHEMBL15462323 0.93 GPR3 (0.50) KDM4EL3MBTL1ATMGPR3MAPT
SCHEMBL9890233 0.93 KDM4E (0.48) KDM4EL3MBTL1ATMGPR3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895966-B2 Material for organic electroluminescence element, and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2014-11-25 US disclosed
US-8895966-B2 Material for organic electroluminescence element, and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2014-11-25 US disclosed
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-04-18 US disclosed
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130092905-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME LEF1, ORMDL3, CD99 KDM4E 1369/4885L3MBTL1 1519/4885ATM 2422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.